Catalyst Wire Dossier Catalyst Wire Dossier

Macular Epiretinal Brachytherapy

not specified
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Macular Epiretinal Brachytherapy, covering 2019-07-22 to 2019-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) [Phase 4]

See pricing